Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...
The growth in Merck's high margin cancer drugs should help expand the company's overall operating margin. Merck supports a strong dividend yield that looks secure based on a wide diversified ...
News Medical on MSN12d
New nanosystem offers hope for improved diagnosis and treatment of tongue cancerA pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback